147 related articles for article (PubMed ID: 25755857)
1. The Expression and Prognostic Impact of CD95 Death Receptor and CD20, CD34 and CD44 Differentiation Markers in Pediatric Acute Lymphoblastic Leukemia.
M Kamazani F; Bahoush-Mehdiabadi G; Aghaeipour M; Vaeli S; Amirghofran Z
Iran J Pediatr; 2014 Aug; 24(4):371-80. PubMed ID: 25755857
[TBL] [Abstract][Full Text] [Related]
2. CD44 and CD27 expression pattern in B cell precursor acute lymphoblastic leukemia and its clinical significance.
Kamazani FM; Bahoush GR; Aghaeipour M; Vaeli S; Amirghofran Z
Med Oncol; 2013 Mar; 30(1):359. PubMed ID: 23263849
[TBL] [Abstract][Full Text] [Related]
3. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
Pituch-Noworolska A
Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
[TBL] [Abstract][Full Text] [Related]
4. No prognostic significance of immunophenotypic changes at the end of remission induction therapy in children with B-lineage acute lymphoblastic leukemia.
Dai Q; Liu X; Yang H; Guo S; Wang Y; Peng L; Ye L; Chen L; Lai C; Chen Q; Zhang G; Jiang Y
Leuk Res; 2018 May; 68():57-61. PubMed ID: 29544133
[TBL] [Abstract][Full Text] [Related]
5. CD34 expression is associated with major adverse prognostic factors in adult acute lymphoblastic leukemia.
Thomas X; Archimbaud E; Charrin C; Magaud JP; Fiere D
Leukemia; 1995 Feb; 9(2):249-53. PubMed ID: 7532767
[TBL] [Abstract][Full Text] [Related]
6. [Minimal residual disease monitoring by flow cytometry in children with acute lymphoblastic leukemia].
Popov AM; Verzhbitskaia TIu; Tsaur GA; Shorikov EV; Savel'ev LI; Tsvirenko SV; Fechina LG
Klin Lab Diagn; 2010 Aug; (8):36-41. PubMed ID: 20886718
[TBL] [Abstract][Full Text] [Related]
7. CD95 (FAS/APO-1) antigen is a new prognostic marker of blast cells of acute lymphoblastic leukaemia patients.
Baryshnikov AYu ; Polosukhina ER; Tupitsin NN; Gavrikova NV; Andreeva LYu ; Zabotina TN; Mayakova SA; Kurmashov VI; Syrkin AB; Kadagidze ZG; Blochin DYu ; Shishkin YuV
Adv Exp Med Biol; 1999; 457():251-8. PubMed ID: 10500800
[TBL] [Abstract][Full Text] [Related]
8. Antigen Expression on Blast Cells and Hematological Parameters at Presentation in Acute Lymphoblastic Leukemia Patients.
Naeem S; Bukhari MH
J Coll Physicians Surg Pak; 2015 Jun; 25(6):407-11. PubMed ID: 26100991
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of CD34 expression in childhood B-precursor acute lymphocytic leukemia: a Pediatric Oncology Group study.
Borowitz MJ; Shuster JJ; Civin CI; Carroll AJ; Look AT; Behm FG; Land VJ; Pullen DJ; Crist WM
J Clin Oncol; 1990 Aug; 8(8):1389-98. PubMed ID: 1696310
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of CD95, Active Caspase-3, and Bcl-2 Expression in Adult Patients with De Novo Acute Lymphoblastic Leukemia.
Montiel-Cervantes LA; Reyes-Maldonado E; Garcia-Chavez J; Hernandez-Caballero A; Molina-Aguilar R; Garcia-Ruiz Esparza MA; Vela-Ojeda J
Arch Med Res; 2018 Jan; 49(1):44-50. PubMed ID: 29680307
[TBL] [Abstract][Full Text] [Related]
11. Adult and childhood acute lymphoblastic leukemia: clinico-biological differences based on CD34 antigen expression.
Cascavilla N; Musto P; D'Arena G; Ladogana S; Matera R; Carotenuto M
Haematologica; 1997; 82(1):31-7. PubMed ID: 9107079
[TBL] [Abstract][Full Text] [Related]
12. [Distribution of antigenic aberration in the bone marrow of acute leukemia in complete remission].
Shin S; Kahng J; Kim M; Lim J; Kim Y; Han K
Korean J Lab Med; 2008 Feb; 28(1):1-7. PubMed ID: 18309249
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience.
Plesa C; Chelghoum Y; Plesa A; Elhamri M; Tigaud I; Michallet M; Dumontet C; Thomas X
Cancer; 2008 Feb; 112(3):572-80. PubMed ID: 18085638
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Impact of Neuropilin-1 Expression in Egyptian Children with B-lineage Acute Lymphoblastic Leukemia.
Hagag AA; Nosair NA
Mediterr J Hematol Infect Dis; 2015; 7(1):e2015009. PubMed ID: 25574368
[TBL] [Abstract][Full Text] [Related]
15. Clinico-prognostic relevance of quantitative immunophenotyping in B-cell chronic lymphocytic leukemia with emphasis on the expression of CD20 antigen and surface immunoglobulins.
Molica S; Levato D; Dattilo A; Mannella A
Eur J Haematol; 1998 Jan; 60(1):47-52. PubMed ID: 9451427
[TBL] [Abstract][Full Text] [Related]
16. CD34 expression is associated with poor survival in pediatric T-cell acute lymphoblastic leukemia.
van Grotel M; van den Heuvel-Eibrink MM; van Wering ER; van Noesel MM; Kamps WA; Veerman AJ; Pieters R; Meijerink JP
Pediatr Blood Cancer; 2008 Dec; 51(6):737-40. PubMed ID: 18683236
[TBL] [Abstract][Full Text] [Related]
17. Leukemia markers expression of peripheral blood vs bone marrow blasts using flow cytometry.
Rezaei A; Adib M; Mokarian F; Tebianian M; Nassiri R
Med Sci Monit; 2003 Aug; 9(8):CR359-62. PubMed ID: 12942032
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of immunophenotypic markers in pediatric T-cell acute lymphoblastic leukemia.
Sidhom I; Shaaban K; Soliman S; Ezzat S; El-Anwar W; Hamdy N; Yassin D; Salem S; Hassanein H; Mansour MT
J Egypt Natl Canc Inst; 2008 Jun; 20(2):111-20. PubMed ID: 20029466
[TBL] [Abstract][Full Text] [Related]
19. Constitutive expression levels of CD95 and Bcl-2 as well as CD95 function and spontaneous apoptosis in vitro do not predict the response to induction chemotherapy and relapse rate in childhood acute lymphoblastic leukaemia.
Wuchter C; Karawajew L; Ruppert V; Schrappe M; Harbott J; Ratei R; Dörken B; Ludwig WD
Br J Haematol; 2000 Jul; 110(1):154-60. PubMed ID: 10930993
[TBL] [Abstract][Full Text] [Related]
20. Lymphoblastic lymphoma.
Cortelazzo S; Ponzoni M; Ferreri AJ; Hoelzer D
Crit Rev Oncol Hematol; 2011 Sep; 79(3):330-43. PubMed ID: 21273093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
